Dan Leonard
Stock Analyst at RBC Capital
(4.82)
# 470
Out of 5,023 analysts
525
Total ratings
63%
Success rate
16.2%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintained: Buy | $215 → $250 | $223.77 | +11.72% | 28 | Oct 5, 2026 | |
| ILMN Illumina | Maintained: Buy | $230 → $310 | $273.90 | +13.18% | 43 | Oct 5, 2026 | |
| BIO Bio-Rad Laboratories | Maintained: Buy | $390 | $387.54 | +0.63% | 31 | Sep 28, 2026 | |
| NTRA Natera | Maintained: Buy | $350 → $460 | $408.79 | +12.53% | 20 | Sep 25, 2026 | |
| GRAL GRAIL | Reiterated: Hold | $84 | $125.21 | -32.91% | 2 | Sep 21, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,350 → $1,515 | $1,519.15 | -0.27% | 15 | Sep 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | $115 → $135 | $150.68 | -10.41% | 19 | Sep 1, 2026 | |
| TXG 10x Genomics | Initiated Coverage: Hold | $20 → $70 | $84.11 | -16.78% | 4 | Sep 1, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $153 → $185 | $172.84 | +7.04% | 36 | Aug 26, 2026 | |
| WAT Waters | Reiterated: Buy | $475 | $430.30 | +10.39% | 26 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 | $72.57 | +0.59% | 22 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $185 → $200 | $176.45 | +13.35% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $14 | $15.38 | -8.97% | 13 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $185 | $190.65 | -2.96% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $490 → $580 | $678.39 | -14.50% | 28 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $64.00 | -29.69% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $10 | $8.89 | +12.49% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $175 | $294.44 | -40.57% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 → $340 | $373.60 | -8.99% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $52 | $44.56 | +16.70% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $240 | $275.02 | -12.73% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $17.40 | -28.16% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $173.90 | +26.51% | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $28 | $21.38 | n/a | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $620.59 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $21.55 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $7.65 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $7 | $29.57 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $320 | $308.95 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 → $145 | $236.59 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $121.97 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.0001 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $35 | $4.14 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $179.23 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.0005 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.37 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.54 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $101.07 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.000001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $1.28 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $0.743 | n/a | 11 | Apr 12, 2016 |
Danaher
Oct 5, 2026
Maintained: Buy
Price Target: $215 → $250
Current: $223.77
Upside: +11.72%
Illumina
Oct 5, 2026
Maintained: Buy
Price Target: $230 → $310
Current: $273.90
Upside: +13.18%
Bio-Rad Laboratories
Sep 28, 2026
Maintained: Buy
Price Target: $390
Current: $387.54
Upside: +0.63%
Natera
Sep 25, 2026
Maintained: Buy
Price Target: $350 → $460
Current: $408.79
Upside: +12.53%
GRAIL
Sep 21, 2026
Reiterated: Hold
Price Target: $84
Current: $125.21
Upside: -32.91%
Mettler-Toledo International
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $1,350 → $1,515
Current: $1,519.15
Upside: -0.27%
Revvity
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $115 → $135
Current: $150.68
Upside: -10.41%
10x Genomics
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $20 → $70
Current: $84.11
Upside: -16.78%
Agilent Technologies
Aug 26, 2026
Reiterated: Buy
Price Target: $153 → $185
Current: $172.84
Upside: +7.04%
Waters
Aug 24, 2026
Reiterated: Buy
Price Target: $475
Current: $430.30
Upside: +10.39%
Aug 12, 2026
Reiterated: Hold
Price Target: $73
Current: $72.57
Upside: +0.59%
Jul 31, 2026
Rated: Buy
Price Target: $185 → $200
Current: $176.45
Upside: +13.35%
Jul 29, 2026
Reiterated: Hold
Price Target: $9 → $14
Current: $15.38
Upside: -8.97%
Jul 28, 2026
Reiterated: Buy
Price Target: $160 → $185
Current: $190.65
Upside: -2.96%
Jul 23, 2026
Reiterated: Hold
Price Target: $490 → $580
Current: $678.39
Upside: -14.50%
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $64.00
Upside: -29.69%
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $8.89
Upside: +12.49%
Feb 25, 2026
Reiterated: Hold
Price Target: $170 → $175
Current: $294.44
Upside: -40.57%
Feb 13, 2026
Reiterated: Buy
Price Target: $355 → $340
Current: $373.60
Upside: -8.99%
Feb 9, 2026
Reiterated: Hold
Price Target: $52
Current: $44.56
Upside: +16.70%
Feb 6, 2026
Reiterated: Buy
Price Target: $280 → $240
Current: $275.02
Upside: -12.73%
Nov 5, 2025
Reiterated: Buy
Price Target: $11 → $13
Current: $17.40
Upside: -28.16%
Oct 24, 2025
Reiterated: Buy
Price Target: $260 → $220
Current: $173.90
Upside: +26.51%
Aug 6, 2025
Reiterated: Hold
Price Target: $24 → $28
Current: $21.38
Upside: n/a
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $620.59
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $21.55
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $11
Current: $7.65
Upside: n/a
Feb 14, 2023
Reiterated: Sell
Price Target: $8 → $7
Current: $29.57
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $340 → $320
Current: $308.95
Upside: n/a
Feb 4, 2022
Reiterated: Hold
Price Target: $160 → $145
Current: $236.59
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $86 → $95
Current: $121.97
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $45 → $35
Current: $4.14
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $179.23
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.0005
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $61.37
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $48.54
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $101.07
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $1.28
Upside: n/a
Apr 12, 2016
Reiterated: Buy
Price Target: $20 → $15
Current: $0.743
Upside: n/a